159 related articles for article (PubMed ID: 8955602)
1. Preoperative assessment of proliferative activity and hormonal receptor status in carcinoma of the breast: a comparison of needle aspiration and needle-core biopsies to the surgical specimen.
Railo M; Nordling S; Krogerus L; Sioris T; von Smitten K
Diagn Cytopathol; 1996 Sep; 15(3):205-10. PubMed ID: 8955602
[TBL] [Abstract][Full Text] [Related]
2. Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer.
Sutela A; Vanninen R; Sudah M; Berg M; Kiviniemi V; Rummukainen J; Kataja V; Kärjä V
Acta Oncol; 2008; 47(1):38-46. PubMed ID: 17851859
[TBL] [Abstract][Full Text] [Related]
3. [Immunohistochemical determination of hormonal receptors on cell-blocks from fine-needle cytopunctures of breast carcinoma].
Briffod M; Le Doussal V; Spyratos F
Bull Cancer; 2001 Oct; 88(10):1028-35. PubMed ID: 11713039
[TBL] [Abstract][Full Text] [Related]
4. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
[TBL] [Abstract][Full Text] [Related]
5. Preoperative profiling of symptomatic breast cancer by diagnostic core biopsy.
Cahill RA; Walsh D; Landers RJ; Watson RG
Ann Surg Oncol; 2006 Jan; 13(1):45-51. PubMed ID: 16378157
[TBL] [Abstract][Full Text] [Related]
6. Primary breast carcinoma: immunocytochemical and immunohistochemical evaluation of biological parameters.
Sianesi M; Bozzetti C; Del Rio P; Nizzoli R; Cascinu S
Chir Ital; 2000; 52(6):643-5. PubMed ID: 11199998
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expression in breast carcinomas: comparison on cell block, needle-core, and tissue block preparations.
Hanley KZ; Birdsong GG; Cohen C; Siddiqui MT
Cancer; 2009 Aug; 117(4):279-88. PubMed ID: 19551847
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical assay of estrogen and progesterone receptors in fine needle aspirates from breast cancer patients.
Nizzoli R; Bozzetti C; Savoldi L; Manotti L; Naldi N; Camisa R; Soresi AP; Guazzi A; Cocconi G
Acta Cytol; 1994; 38(6):933-8. PubMed ID: 7992582
[TBL] [Abstract][Full Text] [Related]
10. Comparison between Ki-67 index and S-phase fraction on fine-needle aspiration samples from breast carcinoma.
Bozzetti C; Nizzoli R; Camisa R; Guazzi A; Ceci G; Cocconi G; Mazzini G; Naldi N
Cancer; 1997 Oct; 81(5):287-92. PubMed ID: 9349516
[TBL] [Abstract][Full Text] [Related]
11. Estrogen and progesterone receptors in the normal female breast.
Ricketts D; Turnbull L; Ryall G; Bakhshi R; Rawson NS; Gazet JC; Nolan C; Coombes RC
Cancer Res; 1991 Apr; 51(7):1817-22. PubMed ID: 2004366
[TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical determination of estrogen and progesterone receptors and flow cytometric DNA analysis of breast cancer on fine needle aspirates.
Marrazzo A; Russo A; Bazan V; Taormina P; Lupo F; Bazan P
Anticancer Res; 1993; 13(6B):2435-40. PubMed ID: 8135480
[TBL] [Abstract][Full Text] [Related]
13. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
Mann GB; Fahey VD; Feleppa F; Buchanan MR
J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
[TBL] [Abstract][Full Text] [Related]
14. Reliability of prognostic factors in breast carcinoma determined by core needle biopsy.
Usami S; Moriya T; Amari M; Suzuki A; Ishida T; Sasano H; Ohuchi N
Jpn J Clin Oncol; 2007 Apr; 37(4):250-5. PubMed ID: 17485439
[TBL] [Abstract][Full Text] [Related]
15. Short-term biologic response to withdrawal of hormone replacement therapy in patients with invasive breast carcinoma.
Prasad R; Boland GP; Cramer A; Anderson E; Knox WF; Bundred NJ
Cancer; 2003 Dec; 98(12):2539-46. PubMed ID: 14669271
[TBL] [Abstract][Full Text] [Related]
16. The role of ThinPrep cytology in the evaluation of estrogen and progesterone receptor content of breast tumors.
Konofaos P; Kontzoglou K; Georgoulakis J; Megalopoulou T; Zoumpouli C; Christoni Z; Papadopoulos O; Kouraklis G; Karakitsos P
Surg Oncol; 2006 Dec; 15(4):257-66. PubMed ID: 17451941
[TBL] [Abstract][Full Text] [Related]
17. The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer.
Park SY; Kim KS; Lee TG; Park SS; Kim SM; Han W; Noh DY; Kim SW
Am J Surg; 2009 Feb; 197(2):266-9. PubMed ID: 18614146
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
Briffod M; Hacène K; Le Doussal V
Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
[TBL] [Abstract][Full Text] [Related]
19. Quantitative assessment of oestrogen and progesterone receptors on fine-needle aspirates and cryostat sections of breast carcinomas: how does this compare with biochemical assays?
Muchiri LW
East Afr Med J; 1993 May; 70(5):280-3. PubMed ID: 8306903
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone hormone receptor status in breast carcinoma: comparison of immunocytochemistry and immunohistochemistry.
Radhika K; Prayaga AK
Indian J Cancer; 2010; 47(2):148-50. PubMed ID: 20448377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]